Search

Sanofi puts agencies on alert in global media pitch

Campaign 29 Jun 2020 10:39

Sanofi, the French pharmaceuticals giant that is involved in the search for a coronavirus vaccine, has kicked off a global media agency review despite the pandemic.

Havas is the incumbent in North America and WPP’s Mindshare manages the business in most of the rest of the world. 

Industry sources say Sanofi has contacted major agency holding companies about the review, although the company did not respond to a request for comment.

MediaSense is understood to be advising on the pitch but would not comment.

Campaign previously reported that Sanofi spent an estimated €900m (£820m) on media at the time of its last media review in 2017.

Sanofi brands include stomach medicine Buscopan, diarrhoea treatment Dioralyte and allergy eye-drop Opticrom.

The comany said it had 6.6% revenue growth in the first quarter of 2020 and is "well-positioned to navigate" the pandemic, given demand from the health sector, including the development of "vaccine candidates and therapeutics" to combat Covid-19.

'Underappreciation for digital marketing'

Continue reading original article...